Reevaluating Anti-Inflammatory Therapy: Targeting Senescence to Balance Anti-Cancer Efficacy and Vascular Disease
Arteriosclerosis, Thrombosis, and Vascular Biology · 2025
DOI: 10.1161/atvbaha.124.319870 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2025. Verfasst von Bernardo Casso-Chapa und 34 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology (B.C.-C., N.A.V.G., N.L.P., V.S.K.S., A.M.O., J.L., G.M., O.H., A.D., S.W.Y., C.A.I., K.C.O.M., S. Kotla, J.-i.A.), The Univ…. Hauptthemen laut MEDLINE: Neoplasms, Cellular Senescence, Anti-Inflammatory Agents, Vascular Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NHLBI NIH HHS, BLRD VA.
Abstract (Originalsprache)
Modulating immune function is a critical strategy in cancer and atherosclerosis treatments. For cancer, boosting or maintaining the immune system is crucial to prevent tumor growth. However, in vascular disease, mitigating immune responses can decrease inflammation and slow atherosclerosis progression. Anti-inflammatory therapy, therefore, presents a unique dilemma for cancer survivors: while it may decrease cardiovascular risk, it might also promote cancer growth and metastasis by suppressing the immune response. Senescence presents a potentially targetable solution to this challenge; senescence increases the risk of both cancer therapy resistance and vascular disease. Exercise, notably, shows promise in delaying this premature senescence, potentially improving cancer outcomes and lowering vascular disease risk post-treatment. This review focuses on the long-term impact of cancer therapies on vascular health. We underscore the importance of modulating senescence to balance cancer treatment’s effectiveness and its vascular impact, and we emphasize investigating the role of exercise-mediated suppression of senescence in improving cancer survivorship.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology (B.C.-C., N.A.V.G., N.L.P., V.S.K.S., A.M.O., J.L., G.M., O.H., A.D., S.W.Y., C.A.I., K.C.O.M., S. Kotla, J.-i.A.), The University of Texas MD Anderson Cancer Center, Houston.
- Instituto Tecnológico y de Estudios Superiores de Monterrey, Escuela de Medicina y Ciencias de la Salud, Nuevo León, México (B.C.-C., N.A.V.G., K.C.O.M.).
- Department of Cardiovascular Sciences, Houston Methodist Research Institute, TX (N.-T.L., G.W., K.M.C.).
- Department of Epidemiology (K.T.N.), The University of Texas MD Anderson Cancer Center, Houston.
- Division of Cancer Center Support Grant & Extramural Research Development (L.P.E.), The University of Texas MD Anderson Cancer Center, Houston.
- Department of Pediatric Research (J.L., K.S.), The University of Texas MD Anderson Cancer Center, Houston.
ORCID-Profile: Bernardo Casso-Chapa, Nhat-Tu Le, Nicolas L Palaskas, Kevin T Nead, Jonghae Lee, Gilbert Mejia, Oanh Hoang, Steven H Lin, Anita Deswal, Guangyu Wang, James L Kirkland, Sunil Krishnan, Xander H T Wehrens, Syed Wamique Yusuf, Cezar A Iliescu, Abhishek Jain, Jared K Burks, Erin Seeley, Philip L Lorenzi, Khanh M Chau, Keila C Ostos-Mendoza, Isabella M Grumbach, Paul S Brookes, Nordin M J Hanssen, Menno P J de Winther, Laurent Yvan-Charvet, Sivareddy Kotla, Keri Schadler, Jun-Ichi Abe
Förderung
- NCI NIH HHS
- NHLBI NIH HHS
- BLRD VA
- NIAID NIH HHS
- NIA NIH HHS
Zitieren
APA
Casso-Chapa, B., Vazquez González, N. A., Le, N. T., Palaskas, N. L., Nead, K. T., Eutsey, L. P., Samanthapudi, V. S. K., Osborn, A. M., Lee, J., Mejia, G., Hoang, O., Lin, S. H., Deswal, A., Herrmann, J., Wang, G., Kirkland, J. L., Krishnan, S., Wehrens, X. H. T., Chini, E. N., …, & Abe, J. I. (2025). Reevaluating Anti-Inflammatory Therapy: Targeting Senescence to Balance Anti-Cancer Efficacy and Vascular Disease. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.124.319870
Vancouver
Casso-Chapa B, Vazquez González NA, Le NT, Palaskas NL, Nead KT, Eutsey LP, et al. Reevaluating Anti-Inflammatory Therapy: Targeting Senescence to Balance Anti-Cancer Efficacy and Vascular Disease. Arteriosclerosis, Thrombosis, and Vascular Biology. 2025. doi:10.1161/atvbaha.124.319870
BibTeX
@article{CassoChapa2025,
author = {Casso-Chapa, Bernardo and Vazquez González, Norma Alicia and Le, Nhat-Tu and Palaskas, Nicolas L and Nead, Kevin T and Eutsey, Lydia P and Samanthapudi, Venkata S K and Osborn, Abigail M and Lee, Jonghae and Mejia, Gilbert and Hoang, Oanh and Lin, Steven H and Deswal, Anita and Herrmann, Joerg and Wang, Guangyu and Kirkland, James L and Krishnan, Sunil and Wehrens, Xander H T and Chini, Eduardo N and Yusuf, Syed Wamique and Iliescu, Cezar A and Jain, Abhishek and Burks, Jared K and Seeley, Erin and Lorenzi, Philip L and Chau, Khanh M and Ostos-Mendoza, Keila C and Grumbach, Isabella M and Brookes, Paul S and Hanssen, Nordin M J and de Winther, Menno P J and Yvan-Charvet, Laurent and Kotla, Sivareddy and Schadler, Keri and Abe, Jun-Ichi},
title = {Reevaluating Anti-Inflammatory Therapy: Targeting Senescence to Balance Anti-Cancer Efficacy and Vascular Disease},
journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
year = {2025},
doi = {10.1161/atvbaha.124.319870}
}
EUVIMED